- Report
- October 2024
- 198 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- February 2025
- 150 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- July 2024
- 180 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- March 2022
- 933 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- June 2023
- 174 Pages
Global
From €4232EUR$4,650USD£3,628GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
The Nanoparticle Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the development of technologies and systems to deliver drugs to their intended targets. Nanoparticle Drug Delivery specifically involves the use of nanoscale particles to deliver drugs to their targets, such as cells, tissues, and organs. This technology has the potential to improve drug efficacy, reduce side effects, and increase the bioavailability of drugs.
Nanoparticle Drug Delivery systems can be used to deliver drugs in a variety of ways, including oral, topical, and intravenous administration. Additionally, they can be used to target specific areas of the body, such as tumors, and can be used to deliver drugs to areas that are difficult to reach with traditional drug delivery systems.
Some companies in the Nanoparticle Drug Delivery market include Nanoform, NanoPass Technologies, NanoViricides, and NanoCarrier. Show Less Read more